This site is intended for healthcare professionals
Unrecognizable female doctor holding graphic virtual visualization model of Lungs organ in hands. Multiple medical icons on the background.
Type 2 Inflammation in COPD
Declaration of sponsorship Sanofi and Regeneron Pharmaceuticals, Inc.

Inflammation in COPD Infographics

Declaration of sponsorship Sanofi and Regeneron Pharmaceuticals, Inc.
Last updated:13th Jun 2024
Published:13th Jun 2024

Pathways to Disease: Inflammation in COPD 

Learn about the pathophysiological processes of chronic obstructive pulmonary disease (COPD), with a specific focus on inflammation and its consequences such as fibrosis/airway remodeling, mucus hypersecretion, barrier disruption, and alveolar wall destruction, which collectively contribute to the clinical impact of the disease.

Learning objectives

  • Understand the pathophysiological mechanisms of COPD, with a specific focus on inflammation and its resulting impacts, including fibrosis/airway remodeling, mucus hypersecretion, barrier disruption, and alveolar wall degradation
  • Gain insights into how the pathophysiology of COPD shapes its clinical manifestation

Pathways to Disease: Inflammation in COPD

Learn about the pathophysiology of COPD and the involvement of chronic inflammation on the airways.

View

Welcome: